Antisense oligonucleotides targeting angiogenic factors as potential cancer therapeutics BT Le, P Raguraman, TR Kosbar, S Fletcher, SD Wilton, RN Veedu Molecular Therapy-Nucleic Acids 14, 142-157, 2019 | 81 | 2019 |
Antisense oligonucleotide-mediated splice switching: potential therapeutic approach for cancer mitigation P Raguraman, AA Balachandran, S Chen, SD Diermeier, RN Veedu Cancers 13 (21), 5555, 2021 | 22 | 2021 |
Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In Vitro P Raguraman, T Wang, L Ma, PT Jørgensen, J Wengel, RN Veedu International Journal of Molecular Sciences 21 (7), 2434, 2020 | 7 | 2020 |
Oligonucleotides containing 2′-O-methyl-5-(1-phenyl-1, 2, 3-triazol-4-yl) uridines demonstrate increased affinity for RNA and induce exon-skipping in vitro AG Molina, P Raguraman, L Delcomyn, RN Veedu, P Nielsen Bioorganic & Medicinal Chemistry 55, 116559, 2022 | 3 | 2022 |
Phosphorothioate modification improves exon-skipping of antisense oligonucleotides based on sulfonyl phosphoramidates in mdx mouse myotubes Y Su, P Raguraman, RN Veedu, VV Filichev Organic & Biomolecular Chemistry 20 (18), 3790-3797, 2022 | 3 | 2022 |
Splice-Switching Antisense Oligonucleotides Targeting Extra-and Intracellular Domains of Epidermal Growth Factor Receptor in Cancer Cells AA Balachandran, P Raguraman, K Rahimizadeh, RN Veedu Biomedicines 11 (12), 3299, 2023 | | 2023 |
Development of novel antisense oligonucleotide molecules towards tackling rare and acquired diseases P Raguraman Murdoch University, 2023 | | 2023 |
Evaluation of Prognostic Impact of p53 Mutant Expression in HPV-Positive and HPV-Negative Head & Neck Squamous cell Carcinomas P Tewari, P Raguraman, R Woods, N Kernan, IS Ochoa, JB O'Crowley, ... LABORATORY INVESTIGATION 99, 2019 | | 2019 |
Morphological and molecular characterization of Microplitis maculipennis Szépligeti (Hymenoptera: Braconidae) from India with notes on its generic placement. T Venkatesan, A Gupta, RP More, P Raguraman, R Baskhar | | 2018 |